| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abruptio Placentae | 28 | 2021 | 118 | 9.930 |
Why?
|
| Pregnancy Complications | 77 | 2022 | 2969 | 8.840 |
Why?
|
| Diabetes, Gestational | 53 | 2024 | 1259 | 6.840 |
Why?
|
| Pre-Eclampsia | 59 | 2023 | 1257 | 5.870 |
Why?
|
| Pregnant Women | 27 | 2022 | 576 | 5.570 |
Why?
|
| Pregnancy | 267 | 2024 | 30179 | 5.150 |
Why?
|
| Peru | 63 | 2022 | 894 | 5.100 |
Why?
|
| Spouse Abuse | 14 | 2018 | 182 | 3.920 |
Why?
|
| Suicidal Ideation | 19 | 2022 | 1466 | 3.750 |
Why?
|
| Migraine Disorders | 30 | 2021 | 1713 | 3.460 |
Why?
|
| Birth Weight | 25 | 2019 | 2117 | 2.770 |
Why?
|
| Adult Survivors of Child Abuse | 9 | 2019 | 302 | 2.720 |
Why?
|
| Premature Birth | 23 | 2021 | 1816 | 2.610 |
Why?
|
| Washington | 39 | 2018 | 314 | 2.520 |
Why?
|
| Stress, Psychological | 20 | 2019 | 4538 | 2.400 |
Why?
|
| Depression | 33 | 2022 | 8235 | 2.360 |
Why?
|
| Students | 15 | 2020 | 1751 | 2.150 |
Why?
|
| Body Mass Index | 60 | 2024 | 13030 | 2.100 |
Why?
|
| Hair | 6 | 2023 | 508 | 2.060 |
Why?
|
| Adult | 295 | 2024 | 223542 | 2.050 |
Why?
|
| Placenta | 15 | 2023 | 1724 | 1.950 |
Why?
|
| Hydrocortisone | 8 | 2023 | 1836 | 1.940 |
Why?
|
| Gestational Age | 30 | 2019 | 3615 | 1.870 |
Why?
|
| Female | 366 | 2024 | 396943 | 1.850 |
Why?
|
| Odds Ratio | 58 | 2019 | 9687 | 1.850 |
Why?
|
| Young Adult | 126 | 2024 | 60045 | 1.800 |
Why?
|
| Depression, Postpartum | 7 | 2019 | 355 | 1.730 |
Why?
|
| Pregnancy Trimester, First | 18 | 2021 | 918 | 1.710 |
Why?
|
| DNA, Mitochondrial | 5 | 2017 | 871 | 1.680 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 9 | 2016 | 1097 | 1.660 |
Why?
|
| Pregnancy Outcome | 28 | 2019 | 2959 | 1.660 |
Why?
|
| Depressive Disorder | 13 | 2018 | 3738 | 1.660 |
Why?
|
| Sleep | 16 | 2022 | 4796 | 1.640 |
Why?
|
| Battered Women | 7 | 2015 | 36 | 1.640 |
Why?
|
| Disabled Children | 4 | 2015 | 251 | 1.620 |
Why?
|
| Risk Factors | 153 | 2024 | 74915 | 1.600 |
Why?
|
| Physical Exertion | 4 | 2019 | 669 | 1.600 |
Why?
|
| Cross-Sectional Studies | 82 | 2024 | 26351 | 1.600 |
Why?
|
| Snoring | 4 | 2017 | 209 | 1.490 |
Why?
|
| Child Abuse | 6 | 2017 | 1092 | 1.460 |
Why?
|
| Prevalence | 58 | 2021 | 15880 | 1.440 |
Why?
|
| Ethiopia | 22 | 2018 | 481 | 1.430 |
Why?
|
| Obesity | 41 | 2024 | 13065 | 1.400 |
Why?
|
| Maternal Age | 22 | 2017 | 809 | 1.370 |
Why?
|
| Anxiety Disorders | 11 | 2022 | 2754 | 1.360 |
Why?
|
| Humans | 392 | 2024 | 768451 | 1.350 |
Why?
|
| Obstetric Labor, Premature | 7 | 2014 | 273 | 1.320 |
Why?
|
| Child Abuse, Sexual | 4 | 2015 | 404 | 1.290 |
Why?
|
| Stillbirth | 5 | 2019 | 376 | 1.280 |
Why?
|
| Logistic Models | 51 | 2022 | 13324 | 1.280 |
Why?
|
| Menarche | 5 | 2024 | 538 | 1.280 |
Why?
|
| Thailand | 15 | 2015 | 288 | 1.250 |
Why?
|
| Case-Control Studies | 69 | 2019 | 22293 | 1.250 |
Why?
|
| Socioeconomic Factors | 39 | 2021 | 7863 | 1.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 12 | 2024 | 4636 | 1.210 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 607 | 1.190 |
Why?
|
| Cadmium | 4 | 2018 | 216 | 1.160 |
Why?
|
| Overweight | 18 | 2019 | 2428 | 1.160 |
Why?
|
| Suicide, Attempted | 5 | 2019 | 1409 | 1.130 |
Why?
|
| Hypertension | 16 | 2023 | 8611 | 1.090 |
Why?
|
| Fetal Membranes, Premature Rupture | 7 | 2018 | 139 | 1.080 |
Why?
|
| Adolescent | 84 | 2024 | 89168 | 1.050 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 243 | 1.040 |
Why?
|
| Glucose Intolerance | 5 | 2017 | 579 | 1.030 |
Why?
|
| Weight Gain | 12 | 2016 | 2357 | 1.010 |
Why?
|
| Placentation | 4 | 2023 | 78 | 1.010 |
Why?
|
| Blood Pressure | 17 | 2019 | 8538 | 1.000 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 585 | 0.960 |
Why?
|
| Cohort Studies | 64 | 2024 | 41797 | 0.950 |
Why?
|
| Prenatal Care | 11 | 2017 | 1159 | 0.950 |
Why?
|
| Pregnancy Trimester, Second | 11 | 2019 | 738 | 0.950 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2016 | 225 | 0.940 |
Why?
|
| Mothers | 11 | 2021 | 2210 | 0.940 |
Why?
|
| Fetal Development | 7 | 2016 | 771 | 0.920 |
Why?
|
| Prospective Studies | 81 | 2021 | 54914 | 0.910 |
Why?
|
| Anger | 4 | 2019 | 405 | 0.890 |
Why?
|
| Maternal Exposure | 6 | 2018 | 1078 | 0.890 |
Why?
|
| Pregnancy Trimesters | 5 | 2015 | 197 | 0.880 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 7 | 2016 | 395 | 0.870 |
Why?
|
| Perinatal Care | 4 | 2018 | 245 | 0.860 |
Why?
|
| Universities | 7 | 2020 | 1007 | 0.850 |
Why?
|
| Infant Mortality | 3 | 2019 | 756 | 0.840 |
Why?
|
| Health Behavior | 7 | 2019 | 2649 | 0.820 |
Why?
|
| Glucose Tolerance Test | 8 | 2018 | 1181 | 0.810 |
Why?
|
| Confidence Intervals | 16 | 2015 | 2932 | 0.790 |
Why?
|
| Health Surveys | 10 | 2019 | 4056 | 0.790 |
Why?
|
| Psychometrics | 11 | 2022 | 3072 | 0.780 |
Why?
|
| Circadian Rhythm | 6 | 2022 | 2585 | 0.780 |
Why?
|
| Social Support | 5 | 2020 | 2195 | 0.770 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2017 | 518 | 0.770 |
Why?
|
| Violence | 3 | 2017 | 937 | 0.770 |
Why?
|
| Sex Offenses | 3 | 2017 | 357 | 0.760 |
Why?
|
| Menstrual Cycle | 5 | 2024 | 542 | 0.750 |
Why?
|
| Gene Dosage | 3 | 2015 | 1221 | 0.750 |
Why?
|
| Anxiety | 7 | 2022 | 4655 | 0.740 |
Why?
|
| C-Reactive Protein | 7 | 2017 | 3854 | 0.740 |
Why?
|
| Genomic Imprinting | 2 | 2020 | 324 | 0.730 |
Why?
|
| Women's Health | 7 | 2022 | 2079 | 0.730 |
Why?
|
| Body Weight | 12 | 2019 | 4630 | 0.720 |
Why?
|
| Uterine Hemorrhage | 2 | 2016 | 240 | 0.720 |
Why?
|
| Sleep Deprivation | 5 | 2015 | 848 | 0.710 |
Why?
|
| Vitamin D | 9 | 2016 | 3311 | 0.710 |
Why?
|
| Smoking | 19 | 2017 | 9099 | 0.700 |
Why?
|
| Hypertension, Pregnancy-Induced | 4 | 2015 | 520 | 0.700 |
Why?
|
| Life Style | 13 | 2017 | 3929 | 0.700 |
Why?
|
| Occupations | 4 | 2013 | 519 | 0.680 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2014 | 708 | 0.670 |
Why?
|
| Chile | 7 | 2022 | 258 | 0.670 |
Why?
|
| Caregivers | 4 | 2015 | 2302 | 0.670 |
Why?
|
| Blood Pressure Determination | 4 | 2015 | 646 | 0.670 |
Why?
|
| Developing Countries | 5 | 2016 | 2901 | 0.660 |
Why?
|
| Ecosystem | 1 | 2024 | 494 | 0.660 |
Why?
|
| Natural Language Processing | 2 | 2018 | 1197 | 0.660 |
Why?
|
| Caffeine | 3 | 2013 | 702 | 0.650 |
Why?
|
| Mass Screening | 8 | 2018 | 5455 | 0.650 |
Why?
|
| Vitamin D Deficiency | 5 | 2015 | 1389 | 0.640 |
Why?
|
| Domestic Violence | 3 | 2010 | 180 | 0.640 |
Why?
|
| Motor Activity | 9 | 2017 | 2722 | 0.630 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2018 | 583 | 0.630 |
Why?
|
| Cross-Cultural Comparison | 5 | 2015 | 639 | 0.630 |
Why?
|
| Depressive Disorder, Major | 7 | 2016 | 4816 | 0.630 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 4049 | 0.630 |
Why?
|
| Life Change Events | 3 | 2015 | 964 | 0.620 |
Why?
|
| Infant, Newborn | 35 | 2021 | 26395 | 0.620 |
Why?
|
| Waist Circumference | 5 | 2019 | 935 | 0.610 |
Why?
|
| Mental Disorders | 7 | 2022 | 6879 | 0.610 |
Why?
|
| Sleep Apnea Syndromes | 4 | 2015 | 981 | 0.600 |
Why?
|
| Oscillometry | 2 | 2015 | 150 | 0.600 |
Why?
|
| Mood Disorders | 4 | 2012 | 1128 | 0.590 |
Why?
|
| Infant, Low Birth Weight | 8 | 2019 | 875 | 0.590 |
Why?
|
| Reproducibility of Results | 22 | 2022 | 20231 | 0.580 |
Why?
|
| Prenatal Diagnosis | 4 | 2014 | 1274 | 0.580 |
Why?
|
| Comorbidity | 17 | 2017 | 10601 | 0.580 |
Why?
|
| Lipids | 10 | 2017 | 3346 | 0.570 |
Why?
|
| Beverages | 2 | 2013 | 822 | 0.570 |
Why?
|
| Fetal Blood | 2 | 2014 | 1353 | 0.560 |
Why?
|
| Saliva | 4 | 2019 | 854 | 0.550 |
Why?
|
| Maternal Welfare | 5 | 2014 | 113 | 0.550 |
Why?
|
| Labor, Induced | 1 | 2018 | 152 | 0.550 |
Why?
|
| Blood Glucose | 12 | 2023 | 6429 | 0.550 |
Why?
|
| Leisure Activities | 6 | 2018 | 310 | 0.550 |
Why?
|
| Family Conflict | 2 | 2015 | 95 | 0.540 |
Why?
|
| Parturition | 2 | 2018 | 453 | 0.540 |
Why?
|
| Insulin Resistance | 4 | 2023 | 3974 | 0.540 |
Why?
|
| Dyslipidemias | 3 | 2017 | 874 | 0.530 |
Why?
|
| Male | 113 | 2023 | 364781 | 0.530 |
Why?
|
| Asthma | 6 | 2017 | 6274 | 0.530 |
Why?
|
| Diet | 9 | 2018 | 8098 | 0.530 |
Why?
|
| Leptin | 6 | 2015 | 1598 | 0.530 |
Why?
|
| Health Status | 5 | 2019 | 4096 | 0.520 |
Why?
|
| Fatty Acids, Omega-3 | 8 | 2016 | 1398 | 0.520 |
Why?
|
| Child of Impaired Parents | 1 | 2019 | 463 | 0.510 |
Why?
|
| Extraembryonic Membranes | 1 | 2015 | 38 | 0.510 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.510 |
Why?
|
| Physical Examination | 5 | 2014 | 1262 | 0.510 |
Why?
|
| Chorion | 1 | 2015 | 112 | 0.500 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 50 | 0.500 |
Why?
|
| Urban Population | 5 | 2018 | 2047 | 0.500 |
Why?
|
| Lipoproteins | 2 | 2015 | 880 | 0.500 |
Why?
|
| Fatigue | 2 | 2014 | 1556 | 0.500 |
Why?
|
| Risk | 20 | 2017 | 9642 | 0.500 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2014 | 415 | 0.500 |
Why?
|
| Calcium, Dietary | 2 | 2016 | 533 | 0.490 |
Why?
|
| Central Nervous System Stimulants | 3 | 2013 | 1180 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 4 | 2022 | 1890 | 0.490 |
Why?
|
| Periodontal Diseases | 2 | 2009 | 455 | 0.490 |
Why?
|
| ARNTL Transcription Factors | 1 | 2015 | 97 | 0.490 |
Why?
|
| Organ Size | 4 | 2015 | 2268 | 0.490 |
Why?
|
| Factor Analysis, Statistical | 6 | 2018 | 1007 | 0.480 |
Why?
|
| Occupational Medicine | 2 | 2012 | 118 | 0.480 |
Why?
|
| Psychotic Disorders | 3 | 2019 | 3278 | 0.480 |
Why?
|
| Mitochondria | 3 | 2018 | 3672 | 0.480 |
Why?
|
| Middle Aged | 66 | 2024 | 223418 | 0.480 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2014 | 554 | 0.470 |
Why?
|
| Exercise | 11 | 2018 | 5940 | 0.460 |
Why?
|
| Amnion | 1 | 2015 | 202 | 0.460 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2017 | 6035 | 0.460 |
Why?
|
| Minority Groups | 2 | 2021 | 1215 | 0.460 |
Why?
|
| Child | 37 | 2024 | 80863 | 0.460 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2014 | 72 | 0.450 |
Why?
|
| Pyruvates | 1 | 2014 | 83 | 0.450 |
Why?
|
| Cross-Over Studies | 6 | 2019 | 2103 | 0.450 |
Why?
|
| International Cooperation | 1 | 2020 | 1439 | 0.450 |
Why?
|
| Parity | 8 | 2014 | 939 | 0.450 |
Why?
|
| Fasting | 3 | 2015 | 1608 | 0.450 |
Why?
|
| Cesarean Section | 2 | 2018 | 1414 | 0.450 |
Why?
|
| Sex Factors | 21 | 2019 | 10647 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2024 | 16029 | 0.450 |
Why?
|
| Migraine without Aura | 1 | 2014 | 82 | 0.450 |
Why?
|
| Pilot Projects | 12 | 2021 | 8730 | 0.440 |
Why?
|
| Iron, Dietary | 2 | 2011 | 149 | 0.440 |
Why?
|
| Metals | 1 | 2018 | 713 | 0.440 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 925 | 0.440 |
Why?
|
| Allostasis | 1 | 2014 | 73 | 0.440 |
Why?
|
| Recreation | 5 | 2008 | 125 | 0.430 |
Why?
|
| Self Report | 6 | 2017 | 3771 | 0.430 |
Why?
|
| Physical Fitness | 4 | 2022 | 744 | 0.430 |
Why?
|
| Multivariate Analysis | 13 | 2016 | 12096 | 0.420 |
Why?
|
| Thinness | 3 | 2014 | 483 | 0.420 |
Why?
|
| Body Height | 4 | 2016 | 1568 | 0.410 |
Why?
|
| Gene Expression | 5 | 2015 | 7605 | 0.410 |
Why?
|
| Needs Assessment | 2 | 2018 | 1146 | 0.410 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 462 | 0.410 |
Why?
|
| MicroRNAs | 5 | 2018 | 3805 | 0.410 |
Why?
|
| Actigraphy | 2 | 2015 | 526 | 0.410 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2006 | 692 | 0.410 |
Why?
|
| Migraine with Aura | 1 | 2014 | 204 | 0.400 |
Why?
|
| Atherosclerosis | 4 | 2017 | 3431 | 0.400 |
Why?
|
| Cardiovascular Diseases | 13 | 2024 | 15638 | 0.400 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2024 | 18048 | 0.400 |
Why?
|
| Pandemics | 8 | 2024 | 8753 | 0.400 |
Why?
|
| Malus | 2 | 2022 | 51 | 0.400 |
Why?
|
| Coercion | 2 | 2009 | 69 | 0.390 |
Why?
|
| DNA Damage | 2 | 2013 | 2461 | 0.390 |
Why?
|
| Northwestern United States | 3 | 2018 | 20 | 0.390 |
Why?
|
| Homocysteine | 2 | 2006 | 637 | 0.390 |
Why?
|
| Epidemiology | 1 | 2014 | 280 | 0.390 |
Why?
|
| Achievement | 1 | 2013 | 288 | 0.390 |
Why?
|
| Unemployment | 1 | 2013 | 210 | 0.390 |
Why?
|
| Sexual Partners | 3 | 2013 | 806 | 0.380 |
Why?
|
| Triglycerides | 10 | 2019 | 2465 | 0.380 |
Why?
|
| Age Distribution | 6 | 2018 | 2881 | 0.380 |
Why?
|
| Interviews as Topic | 9 | 2017 | 2733 | 0.380 |
Why?
|
| Registries | 8 | 2021 | 8373 | 0.380 |
Why?
|
| Postpartum Period | 3 | 2015 | 1197 | 0.380 |
Why?
|
| Mental Health | 6 | 2021 | 3271 | 0.370 |
Why?
|
| Environmental Pollutants | 2 | 2018 | 1290 | 0.370 |
Why?
|
| Waist-Hip Ratio | 2 | 2018 | 520 | 0.370 |
Why?
|
| Seasons | 4 | 2023 | 1526 | 0.370 |
Why?
|
| Environmental Exposure | 5 | 2021 | 4533 | 0.370 |
Why?
|
| Regression Analysis | 6 | 2017 | 6353 | 0.370 |
Why?
|
| United States | 29 | 2024 | 73121 | 0.370 |
Why?
|
| Electronic Health Records | 2 | 2018 | 4877 | 0.360 |
Why?
|
| Parabens | 3 | 2017 | 117 | 0.360 |
Why?
|
| Dyssomnias | 1 | 2010 | 28 | 0.360 |
Why?
|
| Social Class | 1 | 2019 | 2000 | 0.360 |
Why?
|
| Adiponectin | 5 | 2015 | 1118 | 0.360 |
Why?
|
| Anthropometry | 4 | 2019 | 1343 | 0.360 |
Why?
|
| Adiposity | 4 | 2022 | 1888 | 0.350 |
Why?
|
| Cholesterol, Dietary | 1 | 2011 | 224 | 0.350 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 366 | 0.350 |
Why?
|
| Interpersonal Relations | 4 | 2019 | 1439 | 0.350 |
Why?
|
| Heme | 2 | 2011 | 316 | 0.340 |
Why?
|
| Risk Assessment | 20 | 2021 | 24311 | 0.340 |
Why?
|
| New Zealand | 7 | 2019 | 360 | 0.340 |
Why?
|
| Checklist | 1 | 2017 | 843 | 0.340 |
Why?
|
| Hyperglycemia | 3 | 2023 | 1389 | 0.340 |
Why?
|
| Gastroschisis | 1 | 2011 | 99 | 0.340 |
Why?
|
| Trachoma | 1 | 2009 | 19 | 0.340 |
Why?
|
| Eggs | 1 | 2011 | 182 | 0.330 |
Why?
|
| Toilet Facilities | 1 | 2009 | 26 | 0.330 |
Why?
|
| DNA Methylation | 4 | 2018 | 4421 | 0.330 |
Why?
|
| Body Composition | 4 | 2019 | 2455 | 0.330 |
Why?
|
| Self-Injurious Behavior | 1 | 2015 | 571 | 0.330 |
Why?
|
| Age Factors | 13 | 2024 | 18478 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2017 | 2003 | 0.320 |
Why?
|
| Metabolome | 1 | 2016 | 1009 | 0.320 |
Why?
|
| Seafood | 3 | 2018 | 395 | 0.320 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2024 | 383 | 0.320 |
Why?
|
| Harm Reduction | 1 | 2010 | 144 | 0.310 |
Why?
|
| Lactic Acid | 1 | 2014 | 1140 | 0.310 |
Why?
|
| Telomere | 1 | 2015 | 943 | 0.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2018 | 2538 | 0.310 |
Why?
|
| Vitamins | 2 | 2015 | 1638 | 0.310 |
Why?
|
| Eligibility Determination | 1 | 2012 | 420 | 0.310 |
Why?
|
| Vaccination | 1 | 2020 | 3434 | 0.300 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3116 | 0.300 |
Why?
|
| Water Supply | 1 | 2009 | 204 | 0.300 |
Why?
|
| Suicide | 2 | 2017 | 1608 | 0.300 |
Why?
|
| Perception | 1 | 2014 | 1207 | 0.300 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2046 | 0.300 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3240 | 0.300 |
Why?
|
| Cystatins | 1 | 2008 | 55 | 0.300 |
Why?
|
| Abortion, Spontaneous | 2 | 2003 | 539 | 0.300 |
Why?
|
| Time Factors | 16 | 2024 | 40271 | 0.300 |
Why?
|
| Outpatients | 1 | 2016 | 1607 | 0.290 |
Why?
|
| Health Care Rationing | 2 | 2021 | 436 | 0.290 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 243 | 0.290 |
Why?
|
| Models, Statistical | 2 | 2020 | 5103 | 0.280 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2019 | 464 | 0.280 |
Why?
|
| Hospitalization | 3 | 2018 | 10845 | 0.280 |
Why?
|
| Aggression | 2 | 2009 | 750 | 0.280 |
Why?
|
| Dibutyl Phthalate | 2 | 2017 | 29 | 0.280 |
Why?
|
| Spain | 3 | 2019 | 491 | 0.280 |
Why?
|
| Abortion, Induced | 2 | 2003 | 475 | 0.280 |
Why?
|
| Shellfish | 2 | 2018 | 37 | 0.280 |
Why?
|
| Aging | 2 | 2020 | 8761 | 0.280 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 548 | 0.280 |
Why?
|
| Dietary Fiber | 2 | 2008 | 767 | 0.280 |
Why?
|
| Pregnancy, Unplanned | 1 | 2007 | 86 | 0.270 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1408 | 0.270 |
Why?
|
| Quality of Life | 7 | 2022 | 13497 | 0.270 |
Why?
|
| Leukocytes | 1 | 2015 | 2030 | 0.270 |
Why?
|
| Fetal Death | 3 | 2015 | 438 | 0.270 |
Why?
|
| Epidemiologic Studies | 4 | 2016 | 681 | 0.270 |
Why?
|
| Incidence | 12 | 2021 | 21552 | 0.270 |
Why?
|
| Reproduction | 1 | 2011 | 646 | 0.260 |
Why?
|
| Malondialdehyde | 1 | 2006 | 113 | 0.260 |
Why?
|
| Metabolic Diseases | 3 | 2019 | 685 | 0.260 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 2 | 2005 | 126 | 0.260 |
Why?
|
| Fatty Acids | 1 | 2014 | 1818 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2018 | 6610 | 0.260 |
Why?
|
| Fetal Macrosomia | 3 | 2018 | 138 | 0.260 |
Why?
|
| Morbidity | 1 | 2011 | 1760 | 0.250 |
Why?
|
| Language | 2 | 2018 | 1557 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 3237 | 0.250 |
Why?
|
| World Health Organization | 3 | 2020 | 1328 | 0.250 |
Why?
|
| Yoga | 2 | 2020 | 281 | 0.250 |
Why?
|
| Body Burden | 2 | 2016 | 158 | 0.240 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2023 | 705 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2017 | 12242 | 0.240 |
Why?
|
| Self Concept | 2 | 2008 | 1050 | 0.240 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 12774 | 0.240 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2200 | 0.240 |
Why?
|
| Alcohol Drinking | 4 | 2011 | 4052 | 0.240 |
Why?
|
| Preventive Medicine | 1 | 2006 | 245 | 0.240 |
Why?
|
| Linear Models | 8 | 2015 | 5880 | 0.240 |
Why?
|
| Hemodynamics | 1 | 2015 | 4202 | 0.240 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2518 | 0.230 |
Why?
|
| Peer Group | 1 | 2010 | 697 | 0.230 |
Why?
|
| Diabetes Mellitus | 6 | 2016 | 5887 | 0.230 |
Why?
|
| Periodicity | 1 | 2005 | 348 | 0.230 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.230 |
Why?
|
| Oxidative Stress | 2 | 2015 | 3145 | 0.220 |
Why?
|
| Psychotropic Drugs | 1 | 2009 | 888 | 0.220 |
Why?
|
| Hyperhomocysteinemia | 1 | 2004 | 118 | 0.220 |
Why?
|
| C-Peptide | 1 | 2005 | 444 | 0.220 |
Why?
|
| Hyperuricemia | 1 | 2006 | 223 | 0.220 |
Why?
|
| Educational Status | 4 | 2015 | 2519 | 0.220 |
Why?
|
| Population Surveillance | 4 | 2019 | 2601 | 0.220 |
Why?
|
| Lipase | 1 | 2005 | 321 | 0.220 |
Why?
|
| Medical Oncology | 1 | 2015 | 2347 | 0.210 |
Why?
|
| Causality | 3 | 2015 | 1255 | 0.210 |
Why?
|
| Cholesterol, HDL | 6 | 2006 | 1820 | 0.210 |
Why?
|
| Medical History Taking | 2 | 2018 | 776 | 0.210 |
Why?
|
| Health Status Disparities | 5 | 2020 | 1876 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1660 | 0.210 |
Why?
|
| ROC Curve | 3 | 2016 | 3624 | 0.210 |
Why?
|
| Menorrhagia | 1 | 2022 | 59 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2040 | 0.200 |
Why?
|
| Databases, Factual | 5 | 2019 | 8081 | 0.200 |
Why?
|
| Longitudinal Studies | 11 | 2021 | 14766 | 0.200 |
Why?
|
| Occupational Health | 2 | 2013 | 814 | 0.200 |
Why?
|
| Asia, Southeastern | 2 | 2012 | 115 | 0.200 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 3922 | 0.200 |
Why?
|
| Federal Government | 1 | 2024 | 266 | 0.200 |
Why?
|
| Genetic Loci | 3 | 2024 | 2630 | 0.190 |
Why?
|
| Motivation | 2 | 2020 | 2034 | 0.190 |
Why?
|
| Reproductive History | 1 | 2003 | 210 | 0.190 |
Why?
|
| Primary Prevention | 2 | 2021 | 1189 | 0.190 |
Why?
|
| Catha | 2 | 2013 | 9 | 0.190 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 15965 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 949 | 0.190 |
Why?
|
| Pregnancy, High-Risk | 3 | 2014 | 121 | 0.190 |
Why?
|
| Fetal Distress | 2 | 2018 | 39 | 0.190 |
Why?
|
| Africa South of the Sahara | 2 | 2015 | 750 | 0.180 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2015 | 353 | 0.180 |
Why?
|
| Interview, Psychological | 2 | 2015 | 812 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2005 | 1943 | 0.180 |
Why?
|
| Cytokines | 3 | 2021 | 7449 | 0.180 |
Why?
|
| Alabama | 2 | 2024 | 112 | 0.180 |
Why?
|
| Mental Health Services | 1 | 2012 | 1732 | 0.180 |
Why?
|
| Engineering | 1 | 2020 | 56 | 0.170 |
Why?
|
| Uric Acid | 1 | 2006 | 807 | 0.170 |
Why?
|
| Vitamin A | 1 | 2003 | 611 | 0.170 |
Why?
|
| Carotenoids | 1 | 2003 | 621 | 0.170 |
Why?
|
| Polysomnography | 3 | 2015 | 1864 | 0.170 |
Why?
|
| Carboxyhemoglobin | 2 | 2010 | 83 | 0.170 |
Why?
|
| Erythrocytes | 2 | 2006 | 2422 | 0.170 |
Why?
|
| Propylthiouracil | 1 | 2019 | 68 | 0.170 |
Why?
|
| Glucose | 1 | 2012 | 4355 | 0.170 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 473 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 10358 | 0.170 |
Why?
|
| Ferritins | 1 | 2002 | 601 | 0.170 |
Why?
|
| Famous Persons | 1 | 2020 | 109 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2005 | 2003 | 0.170 |
Why?
|
| Family Practice | 1 | 2002 | 510 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2006 | 1142 | 0.160 |
Why?
|
| Fishes | 2 | 2017 | 605 | 0.160 |
Why?
|
| Magnesium | 2 | 2018 | 816 | 0.160 |
Why?
|
| Lectins | 1 | 2021 | 490 | 0.160 |
Why?
|
| Mesalamine | 2 | 2017 | 134 | 0.160 |
Why?
|
| Vietnam | 2 | 2012 | 416 | 0.160 |
Why?
|
| Mathematics | 1 | 2020 | 704 | 0.160 |
Why?
|
| Infant | 10 | 2019 | 36497 | 0.160 |
Why?
|
| Counseling | 3 | 2015 | 1548 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3412 | 0.160 |
Why?
|
| Vitamin E | 1 | 2003 | 873 | 0.160 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 1948 | 0.160 |
Why?
|
| Population Groups | 2 | 2017 | 208 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 259 | 0.150 |
Why?
|
| Medicaid | 1 | 2012 | 2843 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2015 | 1575 | 0.150 |
Why?
|
| Focus Groups | 2 | 2015 | 1448 | 0.150 |
Why?
|
| Molybdenum | 1 | 2018 | 45 | 0.150 |
Why?
|
| Lactobacillus | 1 | 2019 | 212 | 0.150 |
Why?
|
| Taste | 1 | 2019 | 191 | 0.150 |
Why?
|
| Sperm Motility | 2 | 2016 | 266 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5510 | 0.150 |
Why?
|
| Polymorphism, Genetic | 2 | 2005 | 4249 | 0.150 |
Why?
|
| Electric Countershock | 1 | 2021 | 534 | 0.150 |
Why?
|
| Technology | 1 | 2020 | 296 | 0.150 |
Why?
|
| Leukemia | 1 | 2006 | 1527 | 0.150 |
Why?
|
| Puerperal Disorders | 2 | 2018 | 303 | 0.150 |
Why?
|
| Georgia (Republic) | 2 | 2007 | 39 | 0.150 |
Why?
|
| Fetus | 2 | 2020 | 1883 | 0.150 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 30 | 0.150 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2017 | 69 | 0.150 |
Why?
|
| Science | 1 | 2020 | 239 | 0.150 |
Why?
|
| Parathyroid Neoplasms | 1 | 2019 | 244 | 0.150 |
Why?
|
| Plasticizers | 1 | 2017 | 52 | 0.140 |
Why?
|
| Health Priorities | 1 | 2020 | 379 | 0.140 |
Why?
|
| China | 2 | 2014 | 2398 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 2232 | 0.140 |
Why?
|
| Translating | 2 | 2016 | 144 | 0.140 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.140 |
Why?
|
| Marriage | 1 | 2019 | 352 | 0.140 |
Why?
|
| Chronobiology Disorders | 1 | 2018 | 73 | 0.140 |
Why?
|
| Carbon Monoxide | 2 | 2011 | 551 | 0.140 |
Why?
|
| Databases, Bibliographic | 1 | 2017 | 130 | 0.140 |
Why?
|
| Solanum tuberosum | 1 | 2017 | 47 | 0.140 |
Why?
|
| Boston | 3 | 2014 | 9361 | 0.140 |
Why?
|
| Psychological Theory | 2 | 2018 | 176 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 340 | 0.140 |
Why?
|
| Meditation | 1 | 2020 | 257 | 0.140 |
Why?
|
| Zimbabwe | 3 | 2007 | 135 | 0.140 |
Why?
|
| Sweden | 3 | 2015 | 1382 | 0.140 |
Why?
|
| Air Pollutants | 3 | 2021 | 2905 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2015 | 2772 | 0.130 |
Why?
|
| Heart Rate | 3 | 2017 | 4218 | 0.130 |
Why?
|
| Hazardous Substances | 1 | 2017 | 153 | 0.130 |
Why?
|
| Fertilization | 3 | 2022 | 198 | 0.130 |
Why?
|
| Aged | 18 | 2021 | 171520 | 0.130 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2016 | 44 | 0.130 |
Why?
|
| Cosmetics | 1 | 2017 | 102 | 0.130 |
Why?
|
| Walking | 3 | 2018 | 1202 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 501 | 0.130 |
Why?
|
| Siblings | 2 | 2015 | 829 | 0.130 |
Why?
|
| Medical Records | 3 | 2007 | 1413 | 0.130 |
Why?
|
| Ascorbic Acid | 3 | 2004 | 658 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3202 | 0.130 |
Why?
|
| Vegetables | 2 | 2019 | 1202 | 0.130 |
Why?
|
| Air Pollution | 2 | 2021 | 2364 | 0.130 |
Why?
|
| Iceland | 1 | 2016 | 184 | 0.130 |
Why?
|
| Food Preferences | 1 | 2019 | 399 | 0.130 |
Why?
|
| Epicardial Mapping | 1 | 2015 | 58 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 2 | 2023 | 557 | 0.130 |
Why?
|
| Central Venous Pressure | 1 | 2015 | 80 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 1051 | 0.120 |
Why?
|
| Phthalic Acids | 2 | 2017 | 483 | 0.120 |
Why?
|
| Preconception Care | 2 | 2007 | 143 | 0.120 |
Why?
|
| Antioxidants | 1 | 2003 | 1678 | 0.120 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2015 | 150 | 0.120 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.120 |
Why?
|
| Social Behavior | 2 | 2019 | 1144 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3816 | 0.120 |
Why?
|
| Maternal Behavior | 1 | 2017 | 309 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1892 | 0.120 |
Why?
|
| Statistics as Topic | 4 | 2012 | 2362 | 0.120 |
Why?
|
| Selenium | 1 | 2018 | 419 | 0.120 |
Why?
|
| Prehypertension | 1 | 2015 | 63 | 0.120 |
Why?
|
| Chickens | 1 | 2017 | 860 | 0.120 |
Why?
|
| Decidua | 1 | 2015 | 82 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 2 | 2019 | 1487 | 0.120 |
Why?
|
| Supine Position | 1 | 2015 | 208 | 0.120 |
Why?
|
| House Calls | 1 | 2017 | 171 | 0.120 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 187 | 0.120 |
Why?
|
| Thrombectomy | 1 | 2020 | 706 | 0.120 |
Why?
|
| History, Ancient | 1 | 2015 | 215 | 0.120 |
Why?
|
| Immune System | 1 | 2020 | 801 | 0.120 |
Why?
|
| Carcinoid Tumor | 1 | 2016 | 226 | 0.120 |
Why?
|
| Health Services, Indigenous | 1 | 2015 | 47 | 0.120 |
Why?
|
| Genotype | 3 | 2016 | 13047 | 0.120 |
Why?
|
| Estriol | 1 | 2014 | 54 | 0.120 |
Why?
|
| Telemetry | 1 | 2016 | 200 | 0.120 |
Why?
|
| Arsenic | 1 | 2018 | 362 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1543 | 0.120 |
Why?
|
| Secretory Rate | 1 | 2014 | 81 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 614 | 0.120 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 273 | 0.120 |
Why?
|
| Endometriosis | 1 | 2022 | 873 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4586 | 0.110 |
Why?
|
| Social Environment | 2 | 2021 | 1026 | 0.110 |
Why?
|
| Cholesterol | 5 | 2006 | 2910 | 0.110 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 473 | 0.110 |
Why?
|
| Vagina | 1 | 2019 | 845 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1166 | 0.110 |
Why?
|
| Zinc | 1 | 2018 | 677 | 0.110 |
Why?
|
| Greece | 1 | 2014 | 340 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2016 | 370 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3826 | 0.110 |
Why?
|
| Politics | 1 | 2020 | 821 | 0.110 |
Why?
|
| Chromatography, Liquid | 2 | 2014 | 998 | 0.110 |
Why?
|
| Semen | 1 | 2016 | 349 | 0.110 |
Why?
|
| Family Characteristics | 2 | 2017 | 1002 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2005 | 257 | 0.110 |
Why?
|
| Data Mining | 1 | 2018 | 561 | 0.110 |
Why?
|
| Atrial Flutter | 1 | 2015 | 253 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 2016 | 278 | 0.110 |
Why?
|
| Infant, Premature | 3 | 2011 | 2124 | 0.110 |
Why?
|
| Cultural Competency | 2 | 2017 | 303 | 0.110 |
Why?
|
| Rehabilitation | 1 | 2014 | 131 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 462 | 0.110 |
Why?
|
| Circadian Clocks | 1 | 2015 | 168 | 0.110 |
Why?
|
| Massachusetts | 2 | 2018 | 8908 | 0.110 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2014 | 268 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 457 | 0.110 |
Why?
|
| Multilevel Analysis | 1 | 2013 | 148 | 0.110 |
Why?
|
| Metabolomics | 3 | 2019 | 1675 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1196 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 329 | 0.110 |
Why?
|
| Somatomedins | 1 | 2013 | 179 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 708 | 0.110 |
Why?
|
| Embryo Implantation | 1 | 2015 | 272 | 0.110 |
Why?
|
| Shock | 1 | 2015 | 316 | 0.110 |
Why?
|
| Patient Participation | 1 | 2002 | 1450 | 0.110 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 1998 | 0.110 |
Why?
|
| Laos | 1 | 2012 | 27 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 3 | 2014 | 6091 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
| Biological Clocks | 1 | 2015 | 321 | 0.100 |
Why?
|
| Delphi Technique | 1 | 2017 | 879 | 0.100 |
Why?
|
| Hospital Mortality | 2 | 2018 | 5371 | 0.100 |
Why?
|
| Dizziness | 1 | 2016 | 269 | 0.100 |
Why?
|
| Coronary Disease | 1 | 2007 | 5926 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 835 | 0.100 |
Why?
|
| Urban Health | 2 | 2012 | 535 | 0.100 |
Why?
|
| Follow-Up Studies | 10 | 2019 | 39430 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 94 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2015 | 264 | 0.100 |
Why?
|
| Cambodia | 1 | 2012 | 185 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 635 | 0.100 |
Why?
|
| Pyruvaldehyde | 1 | 2012 | 16 | 0.100 |
Why?
|
| Menstruation Disturbances | 2 | 2024 | 143 | 0.100 |
Why?
|
| Dietary Supplements | 2 | 2016 | 3445 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 9507 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 783 | 0.100 |
Why?
|
| Prolactin | 1 | 2014 | 626 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2002 | 1439 | 0.100 |
Why?
|
| Sunlight | 1 | 2013 | 337 | 0.100 |
Why?
|
| Random Allocation | 1 | 2016 | 2399 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 501 | 0.100 |
Why?
|
| Television | 1 | 2014 | 410 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1795 | 0.100 |
Why?
|
| Meat | 2 | 2011 | 586 | 0.090 |
Why?
|
| Hospitals, General | 1 | 2016 | 807 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2015 | 631 | 0.090 |
Why?
|
| Industry | 1 | 2013 | 366 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2014 | 1197 | 0.090 |
Why?
|
| Hematologic Tests | 1 | 2012 | 240 | 0.090 |
Why?
|
| Headache | 2 | 2010 | 1260 | 0.090 |
Why?
|
| Phenols | 1 | 2015 | 520 | 0.090 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 266 | 0.090 |
Why?
|
| Birth Certificates | 1 | 2011 | 71 | 0.090 |
Why?
|
| Posture | 1 | 2015 | 956 | 0.090 |
Why?
|
| Deoxyguanosine | 1 | 2011 | 96 | 0.090 |
Why?
|
| Nutritional Status | 2 | 2016 | 1623 | 0.090 |
Why?
|
| Denmark | 3 | 2019 | 778 | 0.090 |
Why?
|
| Paternal Age | 1 | 2011 | 87 | 0.090 |
Why?
|
| Reference Values | 3 | 2014 | 4941 | 0.090 |
Why?
|
| Postmenopause | 1 | 2019 | 2519 | 0.090 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 1994 | 0.090 |
Why?
|
| Marital Status | 2 | 2015 | 426 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2022 | 3577 | 0.090 |
Why?
|
| Child, Preschool | 8 | 2021 | 42623 | 0.090 |
Why?
|
| Age of Onset | 1 | 2017 | 3342 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2015 | 1009 | 0.090 |
Why?
|
| Hysterectomy | 1 | 2015 | 863 | 0.090 |
Why?
|
| Empathy | 1 | 2015 | 476 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1701 | 0.090 |
Why?
|
| Los Angeles | 2 | 2021 | 245 | 0.090 |
Why?
|
| Arginine | 2 | 2012 | 923 | 0.090 |
Why?
|
| Social Perception | 3 | 2009 | 434 | 0.090 |
Why?
|
| Executive Function | 1 | 2019 | 1402 | 0.090 |
Why?
|
| Predictive Value of Tests | 7 | 2016 | 15460 | 0.090 |
Why?
|
| Spasms, Infantile | 1 | 2013 | 301 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1905 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2279 | 0.080 |
Why?
|
| Arousal | 1 | 2016 | 1182 | 0.080 |
Why?
|
| Head | 1 | 2016 | 927 | 0.080 |
Why?
|
| Progesterone | 1 | 2014 | 750 | 0.080 |
Why?
|
| Cultural Characteristics | 2 | 2009 | 250 | 0.080 |
Why?
|
| Headache Disorders | 1 | 2012 | 152 | 0.080 |
Why?
|
| Environmental Monitoring | 2 | 2021 | 1464 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 3484 | 0.080 |
Why?
|
| Retrospective Studies | 13 | 2020 | 81834 | 0.080 |
Why?
|
| Heart Atria | 1 | 2015 | 1361 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 1755 | 0.080 |
Why?
|
| Proteins | 1 | 2004 | 6008 | 0.080 |
Why?
|
| Chronic Disease | 3 | 2013 | 9382 | 0.080 |
Why?
|
| Arm | 2 | 2015 | 590 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 144 | 0.080 |
Why?
|
| RNA | 2 | 2009 | 2727 | 0.080 |
Why?
|
| Drinking | 1 | 2010 | 198 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 3267 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7246 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2016 | 542 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 2015 | 1308 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1226 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2699 | 0.080 |
Why?
|
| Bacteria | 1 | 2019 | 2226 | 0.080 |
Why?
|
| Netherlands | 3 | 2021 | 2274 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3438 | 0.080 |
Why?
|
| Particulate Matter | 3 | 2021 | 2614 | 0.080 |
Why?
|
| Sexual Harassment | 1 | 2009 | 82 | 0.080 |
Why?
|
| Cholesterol, LDL | 4 | 2005 | 2396 | 0.080 |
Why?
|
| Weight Loss | 2 | 2013 | 2710 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1409 | 0.080 |
Why?
|
| HIV Infections | 1 | 2015 | 17564 | 0.070 |
Why?
|
| Japan | 1 | 2012 | 1418 | 0.070 |
Why?
|
| Carcinoma | 1 | 2019 | 2341 | 0.070 |
Why?
|
| New York City | 2 | 2021 | 738 | 0.070 |
Why?
|
| Infertility, Female | 1 | 2013 | 764 | 0.070 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2008 | 113 | 0.070 |
Why?
|
| Lysine | 1 | 2012 | 989 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2863 | 0.070 |
Why?
|
| Nitrogen Dioxide | 2 | 2021 | 527 | 0.070 |
Why?
|
| PPAR alpha | 1 | 2008 | 177 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1734 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1395 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6242 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2011 | 12813 | 0.070 |
Why?
|
| Managed Care Programs | 1 | 2012 | 941 | 0.070 |
Why?
|
| Gravidity | 1 | 2006 | 50 | 0.070 |
Why?
|
| Cystatin C | 1 | 2008 | 272 | 0.070 |
Why?
|
| Demography | 1 | 2011 | 1643 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 582 | 0.070 |
Why?
|
| Jaundice, Neonatal | 1 | 2006 | 71 | 0.070 |
Why?
|
| Receptors, Adiponectin | 1 | 2006 | 82 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2013 | 1839 | 0.060 |
Why?
|
| Substance-Related Disorders | 3 | 2013 | 4453 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2019 | 2816 | 0.060 |
Why?
|
| Adenolymphoma | 1 | 2005 | 11 | 0.060 |
Why?
|
| Employment | 1 | 2012 | 1120 | 0.060 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.060 |
Why?
|
| Poverty | 1 | 2017 | 2719 | 0.060 |
Why?
|
| Systole | 1 | 2007 | 938 | 0.060 |
Why?
|
| Eclampsia | 1 | 2006 | 60 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2008 | 752 | 0.060 |
Why?
|
| Sperm Count | 2 | 2016 | 229 | 0.060 |
Why?
|
| Diastole | 1 | 2007 | 784 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2005 | 63 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2008 | 705 | 0.060 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2009 | 373 | 0.060 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2005 | 77 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 351 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2022 | 1145 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 2204 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2008 | 586 | 0.060 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2004 | 26 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2016 | 309 | 0.060 |
Why?
|
| Adipose Tissue | 2 | 2007 | 3335 | 0.060 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2665 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4534 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2005 | 635 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2015 | 3115 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2004 | 208 | 0.050 |
Why?
|
| Program Development | 1 | 2010 | 1296 | 0.050 |
Why?
|
| Pregnancy Proteins | 1 | 2004 | 224 | 0.050 |
Why?
|
| Calcifediol | 2 | 2014 | 160 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2012 | 4138 | 0.050 |
Why?
|
| Interleukin-11 | 1 | 2023 | 59 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2009 | 1139 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 693 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 659 | 0.050 |
Why?
|
| Neurobiology | 1 | 2024 | 138 | 0.050 |
Why?
|
| Finland | 2 | 2015 | 609 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2009 | 1041 | 0.050 |
Why?
|
| Military Personnel | 1 | 2012 | 1264 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4362 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2016 | 2819 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 59680 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 644 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4077 | 0.050 |
Why?
|
| Australia | 2 | 2017 | 1264 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 1021 | 0.050 |
Why?
|
| Coffee | 1 | 2007 | 598 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2012 | 2666 | 0.050 |
Why?
|
| London | 1 | 2002 | 233 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1604 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2006 | 563 | 0.050 |
Why?
|
| North Carolina | 2 | 2013 | 327 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 588 | 0.050 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 14728 | 0.050 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2005 | 306 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2010 | 2508 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2022 | 370 | 0.050 |
Why?
|
| Data Collection | 2 | 2012 | 3329 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2022 | 2243 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 1064 | 0.050 |
Why?
|
| Potassium | 1 | 2005 | 1319 | 0.050 |
Why?
|
| Seizures | 1 | 2013 | 2996 | 0.040 |
Why?
|
| Animals | 7 | 2023 | 169418 | 0.040 |
Why?
|
| Behavior | 1 | 2003 | 545 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3230 | 0.040 |
Why?
|
| Professional Practice | 1 | 2002 | 314 | 0.040 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2019 | 33 | 0.040 |
Why?
|
| Security Measures | 1 | 2020 | 83 | 0.040 |
Why?
|
| Prognosis | 4 | 2016 | 30028 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2003 | 993 | 0.040 |
Why?
|
| Betaine | 1 | 2019 | 90 | 0.040 |
Why?
|
| Citrulline | 1 | 2019 | 107 | 0.040 |
Why?
|
| Canada | 2 | 2015 | 2143 | 0.040 |
Why?
|
| Androgens | 1 | 2007 | 1285 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 853 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2006 | 907 | 0.040 |
Why?
|
| Insulin | 3 | 2023 | 6606 | 0.040 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 682 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2009 | 1818 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2003 | 709 | 0.040 |
Why?
|
| Carnitine | 1 | 2019 | 254 | 0.040 |
Why?
|
| Obstetrics | 1 | 2005 | 676 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2005 | 941 | 0.040 |
Why?
|
| Jet Lag Syndrome | 1 | 2018 | 24 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2019 | 366 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 14158 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2023 | 541 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2006 | 914 | 0.040 |
Why?
|
| England | 1 | 2019 | 533 | 0.040 |
Why?
|
| Stroke | 1 | 2020 | 9791 | 0.040 |
Why?
|
| Fast Foods | 1 | 2019 | 216 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 1557 | 0.030 |
Why?
|
| Fertilization in Vitro | 2 | 2015 | 1297 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5162 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65409 | 0.030 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 2181 | 0.030 |
Why?
|
| Spouses | 1 | 2019 | 286 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2005 | 2450 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2020 | 835 | 0.030 |
Why?
|
| Atrial Function, Right | 1 | 2015 | 32 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2020 | 651 | 0.030 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 64 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2076 | 0.030 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tilt-Table Test | 1 | 2016 | 80 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2018 | 395 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2858 | 0.030 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 17 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Mentors | 1 | 2020 | 672 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2015 | 202 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21156 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 40 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1474 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2008 | 3038 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12561 | 0.030 |
Why?
|
| Paternal Exposure | 1 | 2015 | 99 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2015 | 188 | 0.030 |
Why?
|
| Semen Analysis | 1 | 2016 | 236 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 361 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 509 | 0.030 |
Why?
|
| Parents | 2 | 2009 | 3596 | 0.030 |
Why?
|
| Abdominal Fat | 1 | 2016 | 221 | 0.030 |
Why?
|
| Government | 1 | 2015 | 162 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2015 | 398 | 0.030 |
Why?
|
| Career Choice | 1 | 2020 | 769 | 0.030 |
Why?
|
| Inflammation | 2 | 2023 | 10865 | 0.030 |
Why?
|
| Fruit | 1 | 2019 | 1165 | 0.030 |
Why?
|
| Norway | 1 | 2015 | 501 | 0.030 |
Why?
|
| Diet Records | 1 | 2015 | 427 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 363 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2004 | 4029 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 1882 | 0.030 |
Why?
|
| Africa, Eastern | 1 | 2013 | 76 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2016 | 332 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 402 | 0.030 |
Why?
|
| Hospitals | 1 | 2006 | 3906 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 436 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11930 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 409 | 0.030 |
Why?
|
| Work | 1 | 2013 | 195 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 1706 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2016 | 595 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 11515 | 0.020 |
Why?
|
| Israel | 1 | 2014 | 726 | 0.020 |
Why?
|
| Developed Countries | 1 | 2015 | 451 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2012 | 202 | 0.020 |
Why?
|
| Alleles | 2 | 2016 | 6890 | 0.020 |
Why?
|
| Haplotypes | 2 | 2008 | 2725 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2015 | 655 | 0.020 |
Why?
|
| Coma | 1 | 2015 | 488 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2022 | 2586 | 0.020 |
Why?
|
| Phospholipids | 1 | 2015 | 783 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2015 | 881 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2014 | 401 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3794 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 953 | 0.020 |
Why?
|
| Uterus | 1 | 2015 | 660 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2015 | 702 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4120 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1764 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 623 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2286 | 0.020 |
Why?
|
| Epigenomics | 1 | 2016 | 956 | 0.020 |
Why?
|
| Arteries | 1 | 2015 | 1126 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2901 | 0.020 |
Why?
|
| Fertility | 1 | 2015 | 772 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2016 | 1749 | 0.020 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2010 | 65 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 809 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16712 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 773 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 1084 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2002 | 3629 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4780 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2016 | 1062 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1837 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1249 | 0.020 |
Why?
|
| Oxygen | 1 | 2019 | 4269 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2016 | 875 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2834 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6400 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 987 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2014 | 1322 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2742 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 22386 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3665 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 1244 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 114 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 23638 | 0.020 |
Why?
|
| Decision Making | 1 | 2020 | 3961 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3727 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2358 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18388 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 2671 | 0.020 |
Why?
|
| Testosterone | 1 | 2015 | 2493 | 0.010 |
Why?
|
| Biological Factors | 1 | 2005 | 158 | 0.010 |
Why?
|
| Salivary Glands | 1 | 2005 | 231 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 2013 | 1923 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10125 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 986 | 0.010 |
Why?
|
| Adipocytes | 1 | 2010 | 1199 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 2056 | 0.010 |
Why?
|
| Models, Biological | 2 | 2010 | 9505 | 0.010 |
Why?
|
| Health Personnel | 1 | 2017 | 3384 | 0.010 |
Why?
|
| Tryptophan | 1 | 2005 | 483 | 0.010 |
Why?
|
| California | 1 | 2007 | 1444 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 82045 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2005 | 751 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3901 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2016 | 6410 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13655 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2444 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 2826 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1706 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5909 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5308 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11843 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 1256 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 6309 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 2792 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 3615 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2004 | 1120 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7599 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2012 | 3463 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2013 | 4737 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1797 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1898 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2819 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10784 | 0.010 |
Why?
|
| DNA | 1 | 2008 | 7213 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12875 | 0.010 |
Why?
|
| Dementia | 1 | 2008 | 2723 | 0.010 |
Why?
|
| Heart Failure | 1 | 2015 | 11857 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 8635 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7895 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9623 | 0.000 |
Why?
|
| Brain | 1 | 2013 | 27438 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12174 | 0.000 |
Why?
|